Carl-Gerhard Gottfries

Carl-Gerhard Gottfries, MD, PhD, is a Swedish professor, ME/CFS doctor, and founder of the Gottfries Clinic, Mölndal, Sweden. After developing chronic fatigue syndrome following a case of the flu, he discovered that monthly injections of a staphylococcus aureus vaccine boosted his immune system, successfully allowing him to return to work. He has continued using a staphylococcus vaccine injection every month for over fifty years.

Clinic
Gottfries Clinic AB (Gottfriesmottagningen), was previously financed through the health-care system, but now is privately operated. It is a specialty clinic for the 1) evaluation, diagnosis and treatment of patients with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), chronic fatigue and widespread muscular pain, and 2) research for developing and treatment for such patients. Located at Krokslätts Torg 5, Mölndal, Sweden.

2017 Ramsay Award
A team comprised of Dr. Jonas Bergquist and Dr. Jonas Blomberg of Uppsala University and Dr. Carl-Gerhard Gottfries and Dr. Olof Zachrisson of the Gottfries Clinic were awarded a 2017 Ramsay Award grant from the Solve ME/CFS Initiative for research into biomarkers for initiation (infection) and metabolic derangement in ME/CFS.

Talks and interviews

 * Sept 2014, Interview with Professor Carl-Gerhard Gottfries, Part 1: Background and Vaccine
 * Sept 2014, Interview with Professor Carl-Gerhard Gottfries, Part 2: Experience and The Clinic
 * Sept 2014, Interview with Professor Carl-Gerhard Gottfries, Part 3: The Clinic and Urgent Needs
 * Sept 2014, Interview with Professor Carl-Gerhard Gottfries, Part 4: Continued Research

Notable studies

 * 1997, Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome (Abstract)
 * 1998, Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome (Abstract)
 * 2000, Nickel Allergy is Found in a Majority of Women with Chronic Fatigue Syndrome and Muscle Pain - and may be Triggered by Cigarette Smoke and Dietary Nickel Intake (Abstract)
 * 2002, A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale) (Abstract)
 * 2004, Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement (Abstract)
 * 2006, Long-Term Treatment with a Staphylococcus Toxoid Vaccine in Patients with Fibromyalgia and Chronic Fatigue Syndrome (Abstract)
 * 2011, Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia (Full Text)
 * 2012, No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology (Full Text)
 * 2013, Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis (Full Text)
 * 2015, Response to Vitamin B12 and Folic Acid in Myalgic Encephalomyelitis and Fibromyalgia (Full Text)
 * 2018, Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model (Full Text)
 * 2018, A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)
 * 2019, Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients - (Abstract)


 * 2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts - (Full text)

Learn more

 * 2015 - Carl-Gerhard Gottfries: A Swedish Chronic Fatigue Syndrome Story by Cort Johnson